Search
for
Sort by
Research 871–900 of 879
- Dermoscopy of alopecia areata in restrospective analysis
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Hair Transplantation—From the “Ancient” 4 mm Plugs to the Latest Follicular Unit Excision Technique: 8 Decades of Painful Progress
- Latanoprost
- A Practical Guide to Hair Graft Placement Using the Sharp Implanter Method
- EFFICACY OF TOPICAL MINOXIDIL 5% AND BETAMETHASONE VALERATE 0.1% VERSUS BETAMETHASONE VALERATE 0.1% MONOTHERAPY IN NON-SEGMENTAL VITILIGO
- “Doctor, You Must Examine My Creature Collection!”: A Case Report of Delusional Infestation
- Hypothyroidism, eyelash loss
- Progressive Eyelash Loss and Scale of the Right Eyelid
- 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
- Eyelashes: Anatomical and Physiological Features, Eyelash Loss and Trichomegaly: Review
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
- 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries
- Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata
- Eyelash trichomegaly: Report of a case following diffuse hair loss associated with transient malnutrition
- Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata
- Impact and Management of Loss of Eyebrows and Eyelashes
- Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis
- Eyelash Preservation During Chemotherapy and Topical Prostaglandin Therapy
- Corneal punctate epitheliopathy secondary to trichiasis following eyelash transplantation
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Eyelash alopecia areata: case series and literature review
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2